Release date: 6/1/2023
Expiration date: 6/1/2024
Activity Overview
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act. Content focuses on issues and barriers associated with opioid use disorder as well as treatment planning techniques that can be employed to improve patient care.
Target Audience
All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Describe treatment planning techniques using patient-centered decision-making and evidence-based communication strategies.
- Identify the three types of stigmas and their effect on patients with mental health disorders, substance use disorders (SUD), and in particular patients with opioid use disorder (OUD).
- Discuss legal, ethical, and privacy issues involved in the care of clients with opioid use disorder (OUD).
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. If you have questions about this activity, please contact AKH Inc. at [email protected].
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until 6/1/2025. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.0 contact hour(s) (which includes 0 hour(s) of pharmacology).
Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
AKH Inc., Advancing Knowledge in Healthcare designates this activity for 2.0 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Commercial Support
There is no commercial support for this activity.
Faculty
Margaret A. Clark, MSc, RN, RRT – NPS, CMPP
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C
Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
